The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Increased Risk of Tumor Seeding After Percutaneous Radiofrequency Ablation for Single Hepatocellular Carcinoma
Abstract
Radiofrequency (RF) ablation is an alternative to percutaneous ethanol injection (PEI) for single nonsurgical hepatocellular carcinoma (HCC) and is currently used as adjuvant therapy before liver transplantation. This phase II study assesses the treatment–related complications and response rate of RF for the treatment of single HCC ≤5 cm. Percutaneous RF was performed under conscious sedation and ultrasound (US) guidance with an electrical generator connected to a single cooled–tip electrode. Neoplastic cells in peripheral blood (reverse transcription–polymerase chain reaction for alpha fetoprotein [AFP] messenger RNA) were analyzed before and after RF. Treatment response was assessed by spiral computed tomography (CT) at 1 month and every 3 months by US or spiral CT thereafter. Thirty–two patients (20 men; age 67 ± 4 years; 78% hepatitis C virus; 24 Child–Pugh A) with a mean tumor size of 2.8 cm (25 patients ≤3 cm) were treated by RF (1.25 sessions; mean time, 22.1 ± 2 minutes). Adjuvant PEI was performed in 9 cases. Complete response was achieved in 21 patients (65%), being significantly higher for HCC ≤3 cm (76% vs. 29%, P = .03). After a median follow–up of 10 months, 8 patients showed treatment–related morbidity. Four of them (12.5%) showed biopsy–proven needle–track seeding detected between 4 to 18 months. Neoplastic seeding was related to subcapsular location (P = .009), poor differentiation degree (P = .02), and baseline AFP levels (P = .02). Thus, RF ablation with cooled–tip needle for HCC is associated with a high risk of neoplastic seeding. Iatrogenic dissemination was related to subcapsular location or an invasive tumoral pattern, and has to be considered when selecting curative treatments for HCC or adjuvant therapies before liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Self-citationOkuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Self-citationSmall Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
Curley, S. A., Izzo, F., Delrio, P., Ellis, L. M., Granchi, J., Vallone, P., Fiore, F., Pignata, S., Daniele, B., & Cremona, F. (1999) · Annals of Surgery · doi:10.1097/00000658-199907000-00001 · Cited by 1,068
Livraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., & Torzilli, G. (1995) · Radiology · doi:10.1148/radiology.197.1.7568806 · Cited by 939
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Self-citationPercutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.
Rossi, S., Di Stasi, M., Buscarini, E., Quaretti, P., Garbagnati, F., Squassante, L., Paties, C. T., Silverman, D. E., & Buscarini, L. (1996) · American Journal of Roentgenology · doi:10.2214/ajr.167.3.8751696 · Cited by 760
Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis
Curley, S. A., Izzo, F., Ellis, L. M., Nicolas Vauthey, J., & Vallone, P. (2000) · Annals of Surgery · doi:10.1097/00000658-200009000-00010 · Cited by 731
Radiofrequency Ablation of the Liver: Current Status
McGahan, J. P., & Dodd, G. D. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.1.1760003 · Cited by 583
Goldberg, S. N., Hahn, P. F., Tanabe, K. K., Mueller, P. R., Schima, W., Athanasoulis, C. A., Compton, C. C., Solbiati, L., & Gazelle, G. S. (1998) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(98)70491-9 · Cited by 555
Rossi, S., Garbagnati, F., Lencioni, R., Allgaier, H.-P., Marchianò, A., Fornari, F., Quaretti, P., Tolla, G. D., Ambrosi, C., Mazzaferro, V., et al. (2000) · Radiology · doi:10.1148/radiology.217.1.r00se02119 · Cited by 489
Performance status assessment in cancer patients. An inter-observer variability study
Sørensen, J., Klee, M., Palshof, T., & Hansen, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.140 · Cited by 483
Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies
Pearson, A. S., Izzo, F., Fleming, R. Y. D., et al. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00234-2 · Cited by 372
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
Shiina, S., Tagawa, K., Niwa, Y., Unuma, T., Komatsu, Y., Yoshiura, K., Hamada, E., Takahashi, M., Shiratori, Y., & Terano, A. (1993) · American Journal of Roentgenology · doi:10.2214/ajr.160.5.7682378 · Cited by 370
Castells, A., Bruix, J., Bru, C., Fuster, J., Vilana, R., Navasa, M., Ayuso, C., Boix, L., Visa, J., & Rodés, J. (1993) · Hepatology · doi:10.1002/hep.1840180517 · Cited by 368
Self-citationLlovet, J. M. (2002) · Gut · doi:10.1136/gut.50.1.123 · Cited by 287
Self-citationTreatment of Hepatocellular Carcinoma
Bruix, J. (1997) · Hepatology · doi:10.1002/hep.510250201 · Cited by 277
Self-citationVilana, R., Bruix, J., Bru, C., Ayuso, C., Solé, M., & Rodés, J. (1992) · Hepatology · doi:10.1002/hep.1840160212 · Cited by 270
Self-citationStasi, M. D., Buscarini, L., Livraghi, T., Giorgoi, A., Salmi, A., Sio, I. D., Brunello, F., Solmi, L., Caturelli, E., Magnolfi, F., et al. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709002998 · Cited by 188
Radiofrequency thermal ablation of liver tumors
Rhim, H., & Dodd, G. D. (1999) · Journal of Clinical Ultrasound · doi:10.1002/(sici)1097-0096(199906)27:5<221::aid-jcu1>3.0.co;2-t · Cited by 173
Louha, M., Poussin, K., Ganne‐Carrié, N., Zylberberg, H., Nalpas, B., Nicolet, J., Capron, F., Soubrane, O., Vons, C., Pol, S., et al. (1997) · Hepatology · doi:10.1002/hep.510260430 · Cited by 78
Cited by
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Self-citationEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“In addition, HCC tumors in a subcapsular location or adjacent to the gallbladder have a higher risk of incomplete ablation [275] or major complications [268,276,277].”
BackgroundLlovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Self-citationLivraghi, T., Solbiati, L., Meloni, M. F., Gazelle, G. S., Halpern, E. F., & Goldberg, S. N. (2003) · Radiology · doi:10.1148/radiol.2262012198 · Cited by 1,298
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,099
Self-citation
Metadata
- Authors
- Llovet, J. M., Vilana, R., Brú, C., Bianchi, L., Salmeron, J. M., Boix, L., Ganau, S., Sala, M., Pagès, M., Ayuso, C., Solé, M., Rodés, J., & Bruix, J.
- Venue
- Hepatology
- Published
- 2001-05
- Volume
- 33
- Issue
- 5
- Pages
- 1124-1129
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2103051297
- Cited by
- 759
- References
- 23
- FWCI
- 33.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.